v3.26.1
SCHEDULE OF INTANGIBLE ASSETS WERE DETERMINED TO BE PRODUCT TECHNOLOGIES (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Jul. 25, 2024
Restructuring Cost and Reserve [Line Items]      
SCN-107 $ 70,973,064 $ 76,400,000  
Scienture Inc [Member]      
Restructuring Cost and Reserve [Line Items]      
SCN-107     $ 76,400,000
Scienture Inc [Member] | SCN-102 [Member]      
Restructuring Cost and Reserve [Line Items]      
SCN-107 [1] 23,600,000    
Scienture Inc [Member] | SCN-104 [Member]      
Restructuring Cost and Reserve [Line Items]      
SCN-107 [2] 25,000,000    
Scienture Inc [Member] | SCN-106 [Member]      
Restructuring Cost and Reserve [Line Items]      
SCN-107 [3] 15,000,000    
Scienture Inc [Member] | SCN-107 [Member]      
Restructuring Cost and Reserve [Line Items]      
SCN-107 [4] $ 12,800,000    
[1] SCN-102 received regulatory approval in March 2025.Product commercialization began in the third quarter of 2025.
[2] Management expects SCN-104 to achieve regulatory approval in late 2027 or early 2028, with product commercialization projected to begin in 2028.
[3] Management expects SCN-106 to achieve regulatory approval in 2027 or 2028, with product commercialization projected to begin in 2028.
[4] Management expects SCN-107 to achieve regulatory approval in 2028 or 2029, with product commercialization projected to begin in 2029.